Researcher profile · Semantic Scholar

D. Meyran

h-index: 11
Works: 24
Citations: 789

Most-cited papers

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Lauren Giuffrida, K. Sek, M. Henderson, Junyun Lai +15 more
2021Nature Communications207 citations Open access
Semantic Scholar
PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours
F. Wiede, K. Lu, Xin Du, Shuwei Liang +15 more
2019EMBO Journal121 citations Open access
Semantic Scholar
CDK4/6 inhibition promotes anti-tumor immunity through the induction of T cell memory.
Emily J. Lelliott, Isabella Y. Kong, Magnus Zethoven, Kelly M. Ramsbottom +20 more
2021Cancer Discovery109 citations Open access
Semantic Scholar
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
D. Meyran, J. Zhu, Jeannene Butler, Daniela Tantalo +25 more
2023Science Translational Medicine100 citations
Semantic Scholar
The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletons.
Jia-Jia Pan, L. Lordier, D. Meyran, P. Rameau +8 more
2014Blood76 citations
Semantic Scholar
Immune profiling of pediatric solid tumors.
Rachael L. Terry, D. Meyran, D. Ziegler, M. Haber +3 more
2020Journal of Clinical Investigation41 citations Open access
Semantic Scholar
Early-phenotype CAR-T cells for the treatment of pediatric cancers.
D. Meyran, R. Terry, J.-J. Zhu, M. Haber +5 more
2021Annals of Oncology23 citations Open access
Semantic Scholar
PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
Jessica Li, S. Whelan, M. Kotturi, D. Meyran +6 more
2020Haematologica23 citations Open access
Semantic Scholar
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
Rachael L. Terry, D. Meyran, Emmy D. G. Fleuren, C. Mayoh +8 more
2021Cancers22 citations Open access
Semantic Scholar
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
K. Sek, Amanda X. Y. Chen, Thomas J Cole, Jesse D. Armitage +32 more
2025Nature Communications14 citations Open access
Semantic Scholar
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study.
D. Meyran, A. Petit, J. Guilhot, M. Suttorp +9 more
2020European Journal of Cancer13 citations Open access
Semantic Scholar
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors
Emmy D. G. Fleuren, Rachael L. Terry, D. Meyran, Natacha Omer +4 more
2021Biomedicines10 citations Open access
Semantic Scholar
Advances in CAR T cell immunotherapy for paediatric brain tumours
P. Rao, Liam M. Furst, D. Meyran, C. Mayoh +5 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
C. Mayoh, A. Gifford, Rachael L. Terry, L. Lau +40 more
2022bioRxiv8 citations Open access
Semantic Scholar
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
K. Richardson, S. Keam, J. Zhu, D. Meyran +15 more
2022Haematologica6 citations Open access
Semantic Scholar
Description and Management of Accelerated Phase and Blast Crisis in 21 CML Pediatric Patients
D. Meyran, A. Petit, J. Guilhot, M. Suttorp +8 more
20154 citations Open access
Semantic Scholar
126 Early-phenotype Lewis Y CAR-T cells persist better in vivo and induce solid tumor regression in combination with anti-PD1
D. Meyran, J. Zhu, Jeannene Butler, S. Macdonald +8 more
20203 citations Open access
Semantic Scholar
Development of next generation car's targeting the lewis y antigen for the treatment of cancer
D. Meyran, J. Zhu, J. Buttler, Daniela Tantalo +6 more
2019Cytotherapy1 citations
Semantic Scholar
Exploring novel targets for CAR-T therapy for prostate cancer
J. Zhu, D. Meyran, Jeannene Butler, Daniela Tantalo +5 more
2019Cytotherapy1 citations
Semantic Scholar
Chapter 19 – Amegakaryocytic Thrombocytopenia
D. Meyran, T. Leblanc, S. Giraudier, J. Dalle
20171 citations
Semantic Scholar
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Juvenile Myelomonocytic Leukemia (JMML) in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
D. Meyran, R. Porcher, N. Raus, M. Strullu +5 more
20131 citations Open access
Semantic Scholar
HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
Audrey-Anne Lamoureux, M. Fisher, L. Lemelle, E. Pfaff +78 more
2022Neuro-Oncology0 citations Open access
Semantic Scholar
EARLY-PHENOTYPE LEWIS Y CAR-T CELLS PERSIST BETTER IN VIVO AND INDUCE SOLID TUMOR REGRESSION IN COMBINATION WITH ANTI-PD1
D. Meyran, J. Zhu, J. Butler, S. Macdonald +8 more
20200 citations
Semantic Scholar
PTPN2 deletion in T cells promotes anti-tumour immunity and CAR T cell efficacy in solid tumours
F. Wiede, K. Lu, Xin Du, Shuwei Liang +15 more
2019bioRxiv0 citations Open access
Semantic Scholar

P. Beavis

×7

J. Zhu×6

Rachael L. Terry×6

K. Sek×5

Daniela Tantalo×5

M. Kershaw×5

D. Ziegler×5

M. Haber×5